earnings
confidence high
sentiment neutral
materiality 0.45
Privia Health reaffirms FY2022 adjusted EBITDA guidance of $52M-$56M
Privia Health Group, Inc.
2022-Q2 EPS reported
-$0.26
revenue$649,337,000
- Reiterates full-year 2022 adjusted EBITDA range of $52M-$56M, representing 25.6%-35.3% growth over prior year.
- Expects approximately 90% of adjusted EBITDA to convert to free cash flow.
- No reconciliation provided for non-GAAP forward-looking measures; GAAP equivalents not forecastable without unreasonable effort.
- Guidance subject to risks outlined in annual report and other SEC filings.